We're sorry, but eCampus.com doesn't work properly without JavaScript.
Either your device does not support JavaScript or you do not have JavaScript enabled.
How to enable JavaScript in your browser.
Need help? Call 1-855-252-4222
Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
Valentin Fuster, MD, PhD, former Chairman of the American Heart Association's Committee on Vascular Lesions, Assessing and Modifying the Vulnerable Atherosclerotic Plaque explores the most cutting-edge developments in a field grown richer through technological advances.
1. Cardiovascular defense challenges at the basic, clinical, and population levelsJason C. Kovacic, Jose M. Castellano, and Valentin Fuster
7. Plaque neovascularizationl defense mechanisms, betrayal, or a war in progressPedro R. Moreno, Meeranani Purushothaman, and K-Raman Purushothaman
18. LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaosLina Badimon and Gemma Vilahur
33. Evolving role of molecular imaging for new understanding: targeting myofibroblasts to predict remodeling Hans J. de Haas, Susanne W. van den Borne, Hendrikus H. Boersma, Riemer H.J.A. Slart, Valentin Fuster, and Jagat Narula
42. Molecular targets in heart failure gene therapy: current controversies and translational perspectivesVictor Kairouz, Larissa Lipskaia, Roger J. Hajjar, and Elie R. Chemaly
51. Engineered arterial models to correlate blood flow to tissue biological responseJordi Martorell, Pablo Santomá, José J. Molins, Andrés A. García-Granada, José A. Bea, Elazer R. Edelman, and Mercedes Balcells
57. A bird’s-eye view of cell therapy and tissue engineering for cardiac regenerationCarolina Soler-Botija, Juli R. Bagó, and Antoni Bayes-Genis
66. Umbilical cord blood for cardiovascular cell therapy: from promise to factSantiago Roura, Josep-Maria Pujal, and Antoni Bayes-Genis
71. Heart repair: from natural mechanisms of cardiomyocyte production to the design of new cardiac therapiesSilvia Martin-Puig, Valentín Fuster, and Miguel Torres
82. Energy metabolism plasticity enables stemness programsClifford D.L. Folmes, Timothy J. Nelson, Petras P. Dzeja, and Andre Terzic
90. The future: therapy of myocardial protectionDavid Sanz-Rosa, Jaime Garcia-Prieto, and Borja Ibanez
99. The links between complex coronary disease, cerebrobascular disease, and degenerative brain diseaseJason C. Kovacic, Jose M. Castellano, and Valentin Fuster
106. Optimal lipid targets for the new era of cardiovascular preventionVimal Ramjee, danny J. Eapen, and Laurence S. Sperling
115. Controversies in blood pressure goal guidelines and masked hypertensionRobert A. Phillips
123. Evolving diagnostic and prognostic imaging of the various cardiomyopathiesJavier Sanz
131. The evolving landscape of quality measurement for heart failureAshley A. Fitzgerald, Larry A. Allen, and Frederick A. Masoudi
140. Atrial Fibrillation, Stock, and quality of lifeJason S. Chinitz, Jose M. Castellano, Jason C. Kovacic, and Valentin Fuster
151. Transcatheter aortic valve implantation and cerebrovascular events: the current state of the art Brian G. Hynes and Josep Rodés-Cabau
164. Are we ignoring the dilated thoracic aortia?Jose M. Castellano, Jason C. Kovacic, Javier Sanz, and Valentin Fuster
175. Corrigendum
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.